Perfil
George A.
Skouras has founded Cue Capital LP in 2003, where he currently holds the title of Managing Director.
He is also currently working as a Director at Olatec Therapeutics LLC.
Cargos activos de George A. Skouras
Empresas | Cargo | Inicio |
---|---|---|
Cue Capital LP
Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Director Ejecutivo | 01/01/2003 |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Cue Capital LP
Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Finance |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- George A. Skouras